September 8, 2020 Comments Off on Patent delisted for Abbvie drug KALETRA Posted in: Uncategorized
Annual Drug Patent Expirations for KALETRA Kaletra is a drug marketed by Abbvie and is included in three NDAs. It is available from three suppliers. KALETRA drug price trends. Drug…
The post Patent delisted for Abbvie drug KALETRA appeared first on Dru…
September 8, 2020 Comments Off on Patent delisted for Daiichi Sankyo drug BENICAR Posted in: Uncategorized
Annual Drug Patent Expirations for BENICAR Benicar is a drug marketed by Daiichi Sankyo and is included in two NDAs. It is available from three suppliers. BENICAR drug price trends.…
The post Patent delisted for Daiichi Sankyo drug BENICAR appeared fir…
